GlassScriptPhysician profile
Jeri Humphries
NPI 1760778930
$673.38
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $74.81 · 2023: $170 · 2024: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $157.92 | 2023-2024 | Erleada |
| Antares Pharma, INC. | $59.69 | 2024 | Xyosted |
| Boston Scientific Corporation | $58.52 | 2024 | Tria Firm, Spaceoar Vue System - 10ml |
| Abbvie INC. | $41.47 | 2022 | |
| Myriad Genetic Laboratories, INC. | $35.00 | 2023 | Prolaris |
| Pfizer INC. | $31.88 | 2024 | |
| 180 Medical, INC. | $29.92 | 2024 | |
| Angiodynamics, INC. | $29.81 | 2024 | Nanoknife |
| Dendreon Pharmaceuticals LLC | $24.91 | 2024 | Provenge |
| Halozyme INC | $24.14 | 2023 | |
| Axonics, INC. | $23.92 | 2023 | Axonics |
| Endo USA, INC. | $22.77 | 2024 | Xiaflex |
| Novartis Pharmaceuticals Corporation | $22.12 | 2024 | |
| Sumitomo Pharma America, INC. | $19.95 | 2024 | Orgovyx |
| Melinta Therapeutics, LLC | $17.88 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.59 | 2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $15.46 | 2022 | |
| Convatec INC. | $15.45 | 2023 | |
| Siemens Medical Solutions USA, INC. | $14.23 | 2024 | Uroskop Omnia Max |
| Bayer Healthcare Pharmaceuticals INC. | $12.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeri Humphries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.